Live Oak Health Sciences Fund (LOGSX)

18.99
Net Asset Value
+0.05%
1 Day
-2.21%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.01%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund invests primarily in common stocks of companies engaged in the research- development- production- or distribution of products or services related to health care- medicine- or the life sciences. It will invest at least 80% of its net assets- under normal circumstances- in equity securities of health science companies. The fund invests primarily in common stocks of U.S. companies- but may- to a lesser extent- invest in common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund.

Performance

1 month+1.39% 3 years+3.00%
3 months-1.56% 5 years+10.69%
1 year+2.10% Since inception+7.50%
Data through --

Peer Comparisonvs. Health

 LOGSXCategory
Performance 5-yr return+10.69%+14.29%
Expense ratio1.01%1.29%
Risk 5 year sharpe ratio1.000.89
Net assets$60.5M$2.9B
Average market cap$43.2B$9.8B
Average P/E18.522.0
Portfolio turnover14%14%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOak Associates
Fund manager & tenureMark Oelschlager / 16 Years
Minimal initial investment$2,000.00
Minimum IRA investment--

Holdings

U.S. stock83.22%
International stock14.57%
Cash2.21%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 95.95%
Consumer service 4.05%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen7.45%
ANTM WellPoint6.34%
ESRX Express Scripts Holding Co5.88%
WAT Waters Corp5.54%
BIIB Biogen4.96%
MCK McKesson Corp4.57%
DVA Davita Inc4.33%
GSK GlaxoSmithKline4.19%
CAH Cardinal Health Inc4.13%
AET Aetna4.03%